Breaking News

Quotient Clinical Launches New Identity

New identity depicts extended range of services following acquisitions of Co-Formulate, QS Pharma and SeaView Research

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quotient Clinical, a drug development services organization, has been renamed to Quotient Sciences. Following the acquisitions of Co-Formulate, QS Pharma and SeaView Research, this new identity better depicts the company’s global footprint and extended range of services.   Quotient is focused on providing a portfolio of services, including formulation development, clinical trial and commercial manufacturing, and clinical pharmacology. The company has 700 employees and five operating sites acro...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters